How sleep and circadian rhythms affect substance use risk in adolescents
Circadian rhythms, sleep, and substance use risk during adolescence: Observational, experimental, and longitudinal studies
This study is looking at how sleep habits and body clocks affect the chances of teens aged 12 to 20 using drugs or alcohol, and it will test if improving their sleep can help lower that risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10892096 on NIH RePORTER |
What this research studies
This research investigates the relationship between sleep patterns, circadian rhythms, and the risk of substance use in adolescents aged 12 to 20. It aims to understand how disruptions in sleep and circadian traits during this critical developmental period can increase vulnerability to substance use disorders. The study will involve monitoring sleep patterns in adolescents and testing interventions that manipulate sleep and circadian rhythms to see if these changes can reduce the risk of substance use. Participants will undergo home sleep monitoring followed by laboratory assessments to evaluate their cognitive and behavioral responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who may be experiencing sleep disturbances or are at risk for substance use.
Not a fit: Patients who are outside the age range of 12 to 20 or those with established substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new prevention strategies for substance use disorders in adolescents by targeting sleep and circadian rhythm factors.
How similar studies have performed: Previous research has shown that interventions targeting sleep and circadian rhythms can positively influence behavioral outcomes, suggesting potential success for this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Hasler, Brant P. — University of Pittsburgh at Pittsburgh
- Study coordinator: Hasler, Brant P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.